Johnson & Johnson Expands U.S. Footprint with more than $1 Billion Investment in Next Generation Cell Therapy Manufacturing Facility in Pennsylvania
New Brunswick, N.J. – FEBURARY 18, 2026 – Johnson & Johnson (NYSE: JNJ) (the “Company”), healthcare’s leading, most…